Wave disposables will help make pandemic flu vaccine
Novavax and Wave Biotech are to collaborate on the development of a commercial scale production process for the former's pandemic influenza virus vaccine and other biological products.
Archives for September 13, 2005
DelSite seeks US OK for nasal delivery polymer
DelSite Biotechnologies has filed a Drug Master File (DMF) with the US Food and Drug Administration for an excipient used for drug delivery - called GelSite - used to formulate vaccines, proteins and peptide drugs that are delivered across mucosal...
Biofocus enters new class of compound libraries
BioFocus enters a new class of compound libraries with its collection of novel low molecular weight compounds. The compilation will allow drug researchers to find ligands that bind to proteins without having to invest in specialised structural biology...
Nanotech to make big drug R&D impact
According to a new report nanotechnology tools for drug discovery will grow from $580 million (€471.6 million) in 2004 to $1.1 billion in 2010, driven by corporate R&D and new commercial applications.
Fake drug sales 'could nearly double by 2010'
A US think tank, The Centre for Medicines in the Public Interest, has released a new report projecting counterfeit drug sales to reach $75 billion in 2010, a 92 per cent increase from 2005.